new drugs are brought to market more quickly than in previous decades. Emerging technologies and processes in bioprocess engineering have also had an impact on the drug development process.
This episode of Drug Digest explores new and emerging technologies, such as mass photometry ... and analysis of vast data generated by advanced analytical technologies are revolutionizing the drug ...
Between 2007 and 2016, 77% of Food and Drug Administration-approved new drugs were small molecule treatments, which typically come in the form of pills or tablets.
In conventional drug development, QA processes often ... QA practices that allow for rapid adaptation to new data, changes in the manufacturing process, or updated regulatory requirements.
One study found that the IRA could lead to nearly 80 fewer small molecule treatments over the next 20 years. In addition, less investment in small molecule drug development could result in fewer new ...
India's drug pricing regulator, NPPA, is increasing scrutiny of pharmaceutical companies seeking price exemptions. The NPPA is collaborating with the Indian Patent Office to evaluate applications, ...